Latest Diagnostic and Treatment Modalities for TTP
Keywords:
atypical hemolytic uremic syndrome, complement factors, thrombotic thrombocytopenic purpura, plasmapharesis, eculizumab
Abstract
TTP is a very uncommon disease which used to have very high mortality and morbidity before the introduction of plasmapharesis and immunosup-pressant therapy. Even after the introduction of these modalities, atypical HUS patients had a very grave prognosis and ultimately led to death in many until the introduction of complement inhibitors like eculizumab which is C5a monoclonal antibody. Additionally differentiating typical HUS versus atypical HUS was very difficult but some work on complement markers can be very fruitful in differentiating them.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
James George (2010) George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. 116(20), 4060-4069. https://doi.org/10.1182/blood-2010-07-271445
J. Br (2012) Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thromb-ocytopenic purpura and other thrombotic microan-giopathies. 158(3), 323-335. https://doi.org/10.1111/j.1365-2141.2012.09167.x
Remuzzi G. (1987) HUS and TTP: variable expression of a single entity. 32(2), 292. https://doi.org/10.1038/ki.1987.206
P. Ruggenenti, M. Noris, G. Remuzzi (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura Kidney Int Int J. 91(1), 1-19. https://doi.org/10.1007/s12185-2001;60:831.009-0476-1
J. Br (2003) Allford SL, Hunt BJ, Rose P, et al. Guidelines on the diagnosis and management of the thrombotic microangiopathichaemolyticanaemias. 120(4), 556-573. https://doi.org/10.1046/j.1365-2141.2003.04049.x
Tsai HM. (2003) Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. 14, 1072.
Rock GA, Shumak KH, Buskard NA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. 325(6), 393. https://doi.org/10.1056/nejm199108083250604
Vesely SK, George JN, Lämmle B (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpurahemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. 102(1), 60. https://doi.org/10.1182/blood-2003-01-0193
Joel Moake (2002) Moake JL. Thrombotic microangiopathies. 347(8), 589-600. https://doi.org/10.1056/nejmra020528
J. Sadler (2008) Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. 112(1), 11-18. https://doi.org/10.1182/blood-2008-02-078170
Amorosi EL, Ultmann JE (1966) Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. 45, 139.
Von Baeyer, H. (2002) von Baeyer H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. 6, 320.
B. Wyllie, A. Garg, J. Macnab (2006) Wyllie BF, Garg AX, Macnab J, et al. Thrombotic thrombocytopenicpurpura/haemolyticuraemic syndr-ome: a new index predicting response to plasma exchange. 132, 204.
Michael M, Elliott EJ, Ridley GF (2009) Interventions for haemolyticuraemic syndrome and thrombotic thrombo-cytopenic purpura. CD003595.
Kremer JA, Vesely SK, Terrell DR (2010) Survival and relapse in patients with thrombotic thromboc-ytopenic purpura. 115(8), 1500. https://doi.org/10.1182/blood-2009-09-243790
Al-Akash SI, Almond PS, Savell VH, Gharaybeh SI, Hogue C (2011) Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. 26(4), 613-9. https://doi.org/10.1007/s00467-010-1708-6
J. Jump up^ Zuber, Le Quintrec, M. Sberro-Soussan, R. Loirat, C. Frémeaux-Bacchi, V. Legendre, C. (2011) New insights into postrenal transplant hemolytic uremic syndrome. 7(1), 23-35. https://doi.org/10.1038/nrneph.2010.155
Tsai HM (2010) Pathophysiology of thrombotic thrombocytopenic purpura.
Published
2014-06-25
Issue
Section
License
Copyright (c) 2014 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.